##fileformat=VCFv4.2
##fileDate=20181004
##source=freeBayes v1.1.0
##reference=/tmp/local_ngs_data//GRCh37.fa
##phasing=none
##commandline="/mnt/share/opt/freebayes-1.1.0/bin/freebayes -b Sample_GS150344_01/GS150344_01.bam -f /tmp/local_ngs_data//GRCh37.fa -t /tmp/vc_freebayes_bYYSbw_merged.bed --min-alternate-fraction 0.05 --min-mapping-quality 1 --min-base-quality 10 --min-alternate-qsum 90"
##filter="QUAL > 5 & AO > 2"
##VEP="v93" time="2018-10-04 13:46:43" cache="/mnt/share/opt/ensembl-vep-93.2/cache/homo_sapiens/93_GRCh37" ensembl=93.b4d45ee ensembl-funcgen=93.0c98373 ensembl-io=93.cc29a66 ensembl-variation=93.9b583cc 1000genomes="phase3" COSMIC="81" ClinVar="201706" ESP="20141103" HGMD-PUBLIC="20164" assembly="GRCh37.p13" dbSNP="150" gencode="GENCODE 19" genebuild="2011-04" gnomAD="170228" polyphen="2.2.2" regbuild="1.0" sift="sift5.2.2"
##CADD_PHRED=PHRED-like scaled CADD score
##CADD_RAW=Raw CADD score
##REVEL=Rare Exome Variant Ensemble Learner
##FATHMM_MKL_C=FATHMM-MKL coding score
##FATHMM_MKL_NC=FATHMM-MKL non-coding score
##MaxEntScan_alt=MaxEntScan alternate sequence score
##MaxEntScan_diff=MaxEntScan score difference
##MaxEntScan_ref=MaxEntScan reference sequence score
##GeneSplicer=GeneSplicer predictions
##ada_score=dbscSNV ADA score
##rf_score=dbscSNV RF score
##contig=<ID=chr1,length=249250621>
##contig=<ID=chr10,length=135534747>
##contig=<ID=chr11,length=135006516>
##contig=<ID=chr12,length=133851895>
##contig=<ID=chr13,length=115169878>
##contig=<ID=chr14,length=107349540>
##contig=<ID=chr15,length=102531392>
##contig=<ID=chr16,length=90354753>
##contig=<ID=chr17,length=81195210>
##contig=<ID=chr18,length=78077248>
##contig=<ID=chr19,length=59128983>
##contig=<ID=chr2,length=243199373>
##contig=<ID=chr20,length=63025520>
##contig=<ID=chr21,length=48129895>
##contig=<ID=chr22,length=51304566>
##contig=<ID=chr3,length=198022430>
##contig=<ID=chr4,length=191154276>
##contig=<ID=chr5,length=180915260>
##contig=<ID=chr6,length=171115067>
##contig=<ID=chr7,length=159138663>
##contig=<ID=chr8,length=146364022>
##contig=<ID=chr9,length=141213431>
##contig=<ID=chrGL000191.1,length=106433>
##contig=<ID=chrGL000192.1,length=547496>
##contig=<ID=chrGL000193.1,length=189789>
##contig=<ID=chrGL000194.1,length=191469>
##contig=<ID=chrGL000195.1,length=182896>
##contig=<ID=chrGL000196.1,length=38914>
##contig=<ID=chrGL000197.1,length=37175>
##contig=<ID=chrGL000198.1,length=90085>
##contig=<ID=chrGL000199.1,length=169874>
##contig=<ID=chrGL000200.1,length=187035>
##contig=<ID=chrGL000201.1,length=36148>
##contig=<ID=chrGL000202.1,length=40103>
##contig=<ID=chrGL000203.1,length=37498>
##contig=<ID=chrGL000204.1,length=81310>
##contig=<ID=chrGL000205.1,length=174588>
##contig=<ID=chrGL000206.1,length=41001>
##contig=<ID=chrGL000207.1,length=4262>
##contig=<ID=chrGL000208.1,length=92689>
##contig=<ID=chrGL000209.1,length=159169>
##contig=<ID=chrGL000210.1,length=27682>
##contig=<ID=chrGL000211.1,length=166566>
##contig=<ID=chrGL000212.1,length=186858>
##contig=<ID=chrGL000213.1,length=164239>
##contig=<ID=chrGL000214.1,length=137718>
##contig=<ID=chrGL000215.1,length=172545>
##contig=<ID=chrGL000216.1,length=172294>
##contig=<ID=chrGL000217.1,length=172149>
##contig=<ID=chrGL000218.1,length=161147>
##contig=<ID=chrGL000219.1,length=179198>
##contig=<ID=chrGL000220.1,length=161802>
##contig=<ID=chrGL000221.1,length=155397>
##contig=<ID=chrGL000222.1,length=186861>
##contig=<ID=chrGL000223.1,length=180455>
##contig=<ID=chrGL000224.1,length=179693>
##contig=<ID=chrGL000225.1,length=211173>
##contig=<ID=chrGL000226.1,length=15008>
##contig=<ID=chrGL000227.1,length=128374>
##contig=<ID=chrGL000228.1,length=129120>
##contig=<ID=chrGL000229.1,length=19913>
##contig=<ID=chrGL000230.1,length=43691>
##contig=<ID=chrGL000231.1,length=27386>
##contig=<ID=chrGL000232.1,length=40652>
##contig=<ID=chrGL000233.1,length=45941>
##contig=<ID=chrGL000234.1,length=40531>
##contig=<ID=chrGL000235.1,length=34474>
##contig=<ID=chrGL000236.1,length=41934>
##contig=<ID=chrGL000237.1,length=45867>
##contig=<ID=chrGL000238.1,length=39939>
##contig=<ID=chrGL000239.1,length=33824>
##contig=<ID=chrGL000240.1,length=41933>
##contig=<ID=chrGL000241.1,length=42152>
##contig=<ID=chrGL000242.1,length=43523>
##contig=<ID=chrGL000243.1,length=43341>
##contig=<ID=chrGL000244.1,length=39929>
##contig=<ID=chrGL000245.1,length=36651>
##contig=<ID=chrGL000246.1,length=38154>
##contig=<ID=chrGL000247.1,length=36422>
##contig=<ID=chrGL000248.1,length=39786>
##contig=<ID=chrGL000249.1,length=38502>
##contig=<ID=chrhs37d5,length=35477943>
##contig=<ID=chrMT,length=16569>
##contig=<ID=chrNC_007605,length=171823>
##contig=<ID=chrX,length=155270560>
##contig=<ID=chrY,length=59373566>
##INFO=<ID=AB,Number=A,Type=Float,Description="Allele balance at heterozygous sites: a number between 0 and 1 representing the ratio of reads showing the reference allele to all reads, considering only reads from individuals called as heterozygous">
##INFO=<ID=ABP,Number=A,Type=Float,Description="Allele balance probability at heterozygous sites: Phred-scaled upper-bounds estimate of the probability of observing the deviation between ABR and ABA given E(ABR/ABA) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=AC,Number=A,Type=Integer,Description="Total number of alternate alleles in called genotypes">
##INFO=<ID=AF,Number=A,Type=Float,Description="Estimated allele frequency in the range (0,1]">
##INFO=<ID=AN,Number=.,Type=Integer,Description="Total number of alleles in called genotypes">
##INFO=<ID=AO,Number=A,Type=Integer,Description="Count of full observations of this alternate haplotype.">
##INFO=<ID=CIGAR,Number=A,Type=String,Description="The extended CIGAR representation of each alternate allele, with the exception that '=' is replaced by 'M' to ease VCF parsing.  Note that INDEL alleles do not have the first matched base (which is provided by default, per the spec) referred to by the CIGAR.">
##INFO=<ID=CLINVAR,Number=.,Type=String,Description="/mnt/share/data//dbs/ClinVar/clinvar_20180701_converted.vcf.gz (exact)">
##INFO=<ID=CLINVAR_DETAILS,Number=.,Type=String,Description="DETAILS field from /mnt/share/data//dbs/ClinVar/clinvar_20180701_converted.vcf.gz">
##INFO=<ID=CSQ,Number=.,Type=String,Description="Consequence annotations from Ensembl VEP. Format: Allele|Consequence|IMPACT|SYMBOL|Feature|Feature_type|EXON|INTRON|HGVSc|HGVSp|DOMAINS|SIFT|PolyPhen|Existing_variation|AF|gnomAD_AF|gnomAD_AFR_AF|gnomAD_AMR_AF|gnomAD_EAS_AF|gnomAD_NFE_AF|gnomAD_SAS_AF|EA_AF|AA_AF|CADD_PHRED|REVEL|FATHMM_MKL_C|FATHMM_MKL_NC|MaxEntScan_ref|MaxEntScan_alt|GeneSplicer|ada_score|rf_score|gnomADg_AF|gnomADg_Hom|gnomADg_Hemi|REPEATMASKER|CLINVAR|CLINVAR_DETAILS|PHYLOP|OMIM|HGMD|HGMD_CLASS|HGMD_MUT|HGMD_GENE|HGMD_PHEN|BIOTYPE">
##INFO=<ID=DP,Number=.,Type=Integer,Description="Total read depth at the locus">
##INFO=<ID=DPB,Number=.,Type=Float,Description="Total read depth per bp at the locus; bases in reads overlapping / bases in haplotype">
##INFO=<ID=DPRA,Number=A,Type=Float,Description="Alternate allele depth ratio.  Ratio between depth in samples with each called alternate allele and those without.">
##INFO=<ID=END,Number=1,Type=Integer,Description="Last position (inclusive) in gVCF output record.">
##INFO=<ID=EPP,Number=A,Type=Float,Description="End Placement Probability: Phred-scaled upper-bounds estimate of the probability of observing the deviation between EL and ER given E(EL/ER) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=EPPR,Number=.,Type=Float,Description="End Placement Probability for reference observations: Phred-scaled upper-bounds estimate of the probability of observing the deviation between EL and ER given E(EL/ER) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=gnomADg,Number=.,Type=String,Description="/mnt/share/data//dbs/gnomAD/gnomAD_genome_r2.0.2.vcf.gz (exact)">
##INFO=<ID=gnomADg_AF,Number=.,Type=String,Description="AF field from /mnt/share/data//dbs/gnomAD/gnomAD_genome_r2.0.2.vcf.gz">
##INFO=<ID=gnomADg_Hemi,Number=.,Type=String,Description="Hemi field from /mnt/share/data//dbs/gnomAD/gnomAD_genome_r2.0.2.vcf.gz">
##INFO=<ID=gnomADg_Hom,Number=.,Type=String,Description="Hom field from /mnt/share/data//dbs/gnomAD/gnomAD_genome_r2.0.2.vcf.gz">
##INFO=<ID=GTI,Number=.,Type=Integer,Description="Number of genotyping iterations required to reach convergence or bailout.">
##INFO=<ID=HGMD,Number=.,Type=String,Description="/mnt/share/data//dbs/HGMD/HGMD_PRO_2018_2_fixed.vcf.gz (exact)">
##INFO=<ID=HGMD_CLASS,Number=.,Type=String,Description="CLASS field from /mnt/share/data//dbs/HGMD/HGMD_PRO_2018_2_fixed.vcf.gz">
##INFO=<ID=HGMD_GENE,Number=.,Type=String,Description="GENE field from /mnt/share/data//dbs/HGMD/HGMD_PRO_2018_2_fixed.vcf.gz">
##INFO=<ID=HGMD_MUT,Number=.,Type=String,Description="MUT field from /mnt/share/data//dbs/HGMD/HGMD_PRO_2018_2_fixed.vcf.gz">
##INFO=<ID=HGMD_PHEN,Number=.,Type=String,Description="PHEN field from /mnt/share/data//dbs/HGMD/HGMD_PRO_2018_2_fixed.vcf.gz">
##INFO=<ID=LEN,Number=A,Type=Integer,Description="allele length">
##INFO=<ID=MEANALT,Number=A,Type=Float,Description="Mean number of unique non-reference allele observations per sample with the corresponding alternate alleles.">
##INFO=<ID=MIN_DP,Number=1,Type=Integer,Description="Minimum depth in gVCF output block.">
##INFO=<ID=MQM,Number=A,Type=Float,Description="Mean mapping quality of observed alternate alleles">
##INFO=<ID=MQMR,Number=.,Type=Float,Description="Mean mapping quality of observed reference alleles">
##INFO=<ID=NS,Number=.,Type=Integer,Description="Number of samples with data">
##INFO=<ID=NUMALT,Number=.,Type=Integer,Description="Number of unique non-reference alleles in called genotypes at this position.">
##INFO=<ID=ODDS,Number=.,Type=Float,Description="The log odds ratio of the best genotype combination to the second-best.">
##INFO=<ID=OMIM,Number=.,Type=String,Description="/mnt/share/data//dbs/OMIM/omim.bed.gz (overlap)">
##INFO=<ID=PAIRED,Number=A,Type=Float,Description="Proportion of observed alternate alleles which are supported by properly paired read fragments">
##INFO=<ID=PAIREDR,Number=.,Type=Float,Description="Proportion of observed reference alleles which are supported by properly paired read fragments">
##INFO=<ID=PAO,Number=A,Type=Float,Description="Alternate allele observations, with partial observations recorded fractionally">
##INFO=<ID=PHYLOP,Number=.,Type=String,Description="/mnt/share/data//dbs/phyloP/hg19.100way.phyloP100way.bw (overlap)">
##INFO=<ID=PQA,Number=A,Type=Float,Description="Alternate allele quality sum in phred for partial observations">
##INFO=<ID=PQR,Number=.,Type=Float,Description="Reference allele quality sum in phred for partial observations">
##INFO=<ID=PRO,Number=.,Type=Float,Description="Reference allele observation count, with partial observations recorded fractionally">
##INFO=<ID=QA,Number=A,Type=Integer,Description="Alternate allele quality sum in phred">
##INFO=<ID=QR,Number=.,Type=Integer,Description="Reference allele quality sum in phred">
##INFO=<ID=REPEATMASKER,Number=.,Type=String,Description="/mnt/share/data//dbs/RepeatMasker/RepeatMasker.bed.gz (overlap)">
##INFO=<ID=RO,Number=.,Type=Integer,Description="Count of full observations of the reference haplotype.">
##INFO=<ID=RPL,Number=A,Type=Float,Description="Reads Placed Left: number of reads supporting the alternate balanced to the left (5') of the alternate allele">
##INFO=<ID=RPP,Number=A,Type=Float,Description="Read Placement Probability: Phred-scaled upper-bounds estimate of the probability of observing the deviation between RPL and RPR given E(RPL/RPR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RPPR,Number=.,Type=Float,Description="Read Placement Probability for reference observations: Phred-scaled upper-bounds estimate of the probability of observing the deviation between RPL and RPR given E(RPL/RPR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RPR,Number=A,Type=Float,Description="Reads Placed Right: number of reads supporting the alternate balanced to the right (3') of the alternate allele">
##INFO=<ID=RUN,Number=A,Type=Integer,Description="Run length: the number of consecutive repeats of the alternate allele in the reference genome">
##INFO=<ID=SAF,Number=A,Type=Integer,Description="Number of alternate observations on the forward strand">
##INFO=<ID=SAP,Number=A,Type=Float,Description="Strand balance probability for the alternate allele: Phred-scaled upper-bounds estimate of the probability of observing the deviation between SAF and SAR given E(SAF/SAR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=SAR,Number=A,Type=Integer,Description="Number of alternate observations on the reverse strand">
##INFO=<ID=SRF,Number=.,Type=Integer,Description="Number of reference observations on the forward strand">
##INFO=<ID=SRP,Number=.,Type=Float,Description="Strand balance probability for the reference allele: Phred-scaled upper-bounds estimate of the probability of observing the deviation between SRF and SRR given E(SRF/SRR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=SRR,Number=.,Type=Integer,Description="Number of reference observations on the reverse strand">
##INFO=<ID=technology.ILLUMINA,Number=A,Type=Float,Description="Fraction of observations supporting the alternate observed in reads from ILLUMINA">
##INFO=<ID=TYPE,Number=A,Type=String,Description="The type of allele, either snp, mnp, ins, del, or complex.">
##FORMAT=<ID=AD,Number=R,Type=Integer,Description="Number of observation for each allele">
##FORMAT=<ID=AO,Number=A,Type=Integer,Description="Alternate allele observation count">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read Depth">
##FORMAT=<ID=GL,Number=G,Type=Float,Description="Genotype Likelihood, log10-scaled likelihoods of the data given the called genotype for each possible genotype generated from the reference and alternate alleles given the sample ploidy">
##FORMAT=<ID=GQ,Number=1,Type=Float,Description="Genotype Quality, the Phred-scaled marginal (or unconditional) probability of the called genotype">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=MIN_DP,Number=1,Type=Integer,Description="Minimum depth in gVCF output block.">
##FORMAT=<ID=QA,Number=A,Type=Integer,Description="Sum of quality of the alternate observations">
##FORMAT=<ID=QR,Number=1,Type=Integer,Description="Sum of quality of the reference observations">
##FORMAT=<ID=RO,Number=1,Type=Integer,Description="Reference allele observation count">
##SAMPLE=<ID=GS150344_01,Gender=female,ExternalSampleName=151172,IsTumor=yes,IsFFPE=yes,DiseaseGroup=Neoplasms,DiseaseStatus=Affected>
##INFO=<ID=mmsplice,Number=.,Type=String,Description="mmsplice splice variant effect: delta_logit_psi(logit scale of variant's effect on the exon inclusion, positive score shows higher exon inclusion, negative higher exclusion rate - a score beyond 2, -2 can be considered strong); pathogenicity(Potential pathogenic effect of the variant)">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	GS150344_01
chr13	32911888	.	A	G	4875	.	MQM=60;CADD_SNV=0.343;CSQ=G|synonymous_variant|LOW|BRCA2|ENST00000380152|Transcript|11/27||ENST00000380152.3:c.3396A>G|ENSP00000369497.3:p.Lys1132%3D|PIRSF_domain:PIRSF002397&hmmpanther:PTHR11289&hmmpanther:PTHR11289:SF0|||rs1801406&COSM4415776|0.2668|0.2947|0.2277|0.2127|0.382|0.3087|0.2994|0.3074|0.2261|0.342517||0.48838|0.90465||||||0.29840|1425|||126010|benign[p]Fanconi_anemia[c]Hereditary_cancer-predisposing_syndrome[c]Familial_cancer_of_breast[c]Hereditary_breast_and_ovarian_cancer_syndrome[c]Breast-ovarian_cancer[c]_familial_2[c]not_specified[c]not_provided|0.212999999523163|600185_[BRCA2_(confirmed)_Breast-ovarian_cancer&familial&2&612555/Fanconi_anemia&complementation_group_D1&605724/Prostate_cancer&176807/Breast_cancer&male&susceptibility_to&114480/Wilms_tumor&194070/Medulloblastoma&155255/Glioblastoma_3&613029/Pancreatic_cancer_2&613347]|||||,G|synonymous_variant|LOW|BRCA2|ENST00000544455|Transcript|11/28||ENST00000544455.1:c.3396A>G|ENSP00000439902.1:p.Lys1132%3D|PIRSF_domain:PIRSF002397&hmmpanther:PTHR11289&hmmpanther:PTHR11289:SF0|||rs1801406&COSM4415776|0.2668|0.2947|0.2277|0.2127|0.382|0.3087|0.2994|0.3074|0.2261|0.342517||0.48838|0.90465||||||0.29840|1425|||126010|benign[p]Fanconi_anemia[c]Hereditary_cancer-predisposing_syndrome[c]Familial_cancer_of_breast[c]Hereditary_breast_and_ovarian_cancer_syndrome[c]Breast-ovarian_cancer[c]_familial_2[c]not_specified[c]not_provided|0.212999999523163|600185_[BRCA2_(confirmed)_Breast-ovarian_cancer&familial&2&612555/Fanconi_anemia&complementation_group_D1&605724/Prostate_cancer&176807/Breast_cancer&male&susceptibility_to&114480/Wilms_tumor&194070/Medulloblastoma&155255/Glioblastoma_3&613029/Pancreatic_cancer_2&613347]|||||;mmsplice=[exon:chr13:32910401-32915333:+,delta_logit_psi:0.0033,pathogenicity:0.158]	GT:DP:AO	1/1:149:148
chr13	32913055	.	A	G	5583	.	MQM=60;CADD_SNV=0.027;CSQ=G|synonymous_variant|LOW|BRCA2|ENST00000380152|Transcript|11/27||ENST00000380152.3:c.4563A>G|ENSP00000369497.3:p.Leu1521%3D|Pfam_domain:PF00634&PIRSF_domain:PIRSF002397&PROSITE_profiles:PS50138&hmmpanther:PTHR11289&hmmpanther:PTHR11289:SF0|||rs206075||0.9945|0.9252|0.9956|0.9999|0.9996|0.9999|0.9994|0.9296|0.033385||0.00461|0.26620||||||0.97990|14867|||132779|benign[p]Fanconi_anemia[c]Hereditary_cancer-predisposing_syndrome[c]Familial_cancer_of_breast[c]Hereditary_breast_and_ovarian_cancer_syndrome[c]Breast-ovarian_cancer[c]_familial_2[c]not_specified[c]not_provided|0.0710000023245811|600185_[BRCA2_(confirmed)_Breast-ovarian_cancer&familial&2&612555/Fanconi_anemia&complementation_group_D1&605724/Prostate_cancer&176807/Breast_cancer&male&susceptibility_to&114480/Wilms_tumor&194070/Medulloblastoma&155255/Glioblastoma_3&613029/Pancreatic_cancer_2&613347]|||||,G|synonymous_variant|LOW|BRCA2|ENST00000544455|Transcript|11/28||ENST00000544455.1:c.4563A>G|ENSP00000439902.1:p.Leu1521%3D|Pfam_domain:PF00634&PIRSF_domain:PIRSF002397&PROSITE_profiles:PS50138&hmmpanther:PTHR11289&hmmpanther:PTHR11289:SF0|||rs206075||0.9945|0.9252|0.9956|0.9999|0.9996|0.9999|0.9994|0.9296|0.033385||0.00461|0.26620||||||0.97990|14867|||132779|benign[p]Fanconi_anemia[c]Hereditary_cancer-predisposing_syndrome[c]Familial_cancer_of_breast[c]Hereditary_breast_and_ovarian_cancer_syndrome[c]Breast-ovarian_cancer[c]_familial_2[c]not_specified[c]not_provided|0.0710000023245811|600185_[BRCA2_(confirmed)_Breast-ovarian_cancer&familial&2&612555/Fanconi_anemia&complementation_group_D1&605724/Prostate_cancer&176807/Breast_cancer&male&susceptibility_to&114480/Wilms_tumor&194070/Medulloblastoma&155255/Glioblastoma_3&613029/Pancreatic_cancer_2&613347]|||||;mmsplice=[exon:chr13:32910401-32915333:+,delta_logit_psi:0.0008,pathogenicity:0.1579]	GT:DP:AO	1/1:169:169
chr13	32915005	.	G	C	3321	.	MQM=60;CADD_SNV=0.4487;CSQ=C|synonymous_variant|LOW|BRCA2|ENST00000380152|Transcript|11/27||ENST00000380152.3:c.6513G>C|ENSP00000369497.3:p.Val2171%3D|PIRSF_domain:PIRSF002397&hmmpanther:PTHR11289&hmmpanther:PTHR11289:SF0|||rs206076&COSM4147690||0.9943|0.9251|0.9955|0.9999|0.9995|0.9999|0.9994|0.9287|-0.452665||0.02264|0.12944||||||0.97984|14873|||132780|benign[p]Fanconi_anemia[c]Hereditary_cancer-predisposing_syndrome[c]Familial_cancer_of_breast[c]Hereditary_breast_and_ovarian_cancer_syndrome[c]Breast-ovarian_cancer[c]_familial_2[c]not_specified[c]not_provided|-0.875|600185_[BRCA2_(confirmed)_Breast-ovarian_cancer&familial&2&612555/Fanconi_anemia&complementation_group_D1&605724/Prostate_cancer&176807/Breast_cancer&male&susceptibility_to&114480/Wilms_tumor&194070/Medulloblastoma&155255/Glioblastoma_3&613029/Pancreatic_cancer_2&613347]|||||,C|synonymous_variant|LOW|BRCA2|ENST00000544455|Transcript|11/28||ENST00000544455.1:c.6513G>C|ENSP00000439902.1:p.Val2171%3D|PIRSF_domain:PIRSF002397&hmmpanther:PTHR11289&hmmpanther:PTHR11289:SF0|||rs206076&COSM4147690||0.9943|0.9251|0.9955|0.9999|0.9995|0.9999|0.9994|0.9287|-0.452665||0.02264|0.12944||||||0.97984|14873|||132780|benign[p]Fanconi_anemia[c]Hereditary_cancer-predisposing_syndrome[c]Familial_cancer_of_breast[c]Hereditary_breast_and_ovarian_cancer_syndrome[c]Breast-ovarian_cancer[c]_familial_2[c]not_specified[c]not_provided|-0.875|600185_[BRCA2_(confirmed)_Breast-ovarian_cancer&familial&2&612555/Fanconi_anemia&complementation_group_D1&605724/Prostate_cancer&176807/Breast_cancer&male&susceptibility_to&114480/Wilms_tumor&194070/Medulloblastoma&155255/Glioblastoma_3&613029/Pancreatic_cancer_2&613347]|||||;mmsplice=[exon:chr13:32910401-32915333:+,delta_logit_psi:-0.001,pathogenicity:0.1579]	GT:DP:AO	1/1:102:102
chr13	32929387	.	T	C	4062	.	MQM=60;CADD_SNV=0.8629;CSQ=C|missense_variant|MODERATE|BRCA2|ENST00000380152|Transcript|14/27||ENST00000380152.3:c.7397T>C|ENSP00000369497.3:p.Val2466Ala|PIRSF_domain:PIRSF002397&hmmpanther:PTHR11289&hmmpanther:PTHR11289:SF0|tolerated(0.11)|benign(0.88)|rs169547&CM960194|0.9758|0.995|0.9322|0.9958|0.9999|0.9997|0.9999|0.9994|0.9353|0.863255|0.091|0.00045|0.10087||||||0.98192|14936|||133738|benign[p]Ductal_breast_carcinoma[c]not_specified|2.35199999809265|600185_[BRCA2_(confirmed)_Breast-ovarian_cancer&familial&2&612555/Fanconi_anemia&complementation_group_D1&605724/Prostate_cancer&176807/Breast_cancer&male&susceptibility_to&114480/Wilms_tumor&194070/Medulloblastoma&155255/Glioblastoma_3&613029/Pancreatic_cancer_2&613347]|||||,C|missense_variant|MODERATE|BRCA2|ENST00000544455|Transcript|14/28||ENST00000544455.1:c.7397T>C|ENSP00000439902.1:p.Val2466Ala|PIRSF_domain:PIRSF002397&hmmpanther:PTHR11289&hmmpanther:PTHR11289:SF0|tolerated(0.11)|benign(0.88)|rs169547&CM960194|0.9758|0.995|0.9322|0.9958|0.9999|0.9997|0.9999|0.9994|0.9353|0.863255|0.091|0.00045|0.10087||||||0.98192|14936|||133738|benign[p]Ductal_breast_carcinoma[c]not_specified|2.35199999809265|600185_[BRCA2_(confirmed)_Breast-ovarian_cancer&familial&2&612555/Fanconi_anemia&complementation_group_D1&605724/Prostate_cancer&176807/Breast_cancer&male&susceptibility_to&114480/Wilms_tumor&194070/Medulloblastoma&155255/Glioblastoma_3&613029/Pancreatic_cancer_2&613347]|||||;mmsplice=[exon:chr13:32928997-32929425:+,delta_logit_psi:0.1306,pathogenicity:0.5302]	GT:DP:AO	1/1:123:123
chr17	41226536	.	G	T	1291	.	MQM=60;CADD_SNV=5.761;CSQ=T|stop_gained&splice_region_variant|HIGH|BRCA1|ENST00000309486|Transcript|13/22||ENST00000309486.4:c.3599C>A|ENSP00000310938.4:p.Ser1200Ter|hmmpanther:PTHR13763&hmmpanther:PTHR13763:SF0&PIRSF_domain:PIRSF001734|||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911|12.0025154251982|11.6681915767273||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|intron_variant|MODIFIER|BRCA1|ENST00000346315|Transcript||12/18|ENST00000346315.3:c.4357+7885C>A|||||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911||||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|stop_gained&splice_region_variant|HIGH|BRCA1|ENST00000351666|Transcript|10/19||ENST00000351666.3:c.938C>A|ENSP00000338007.3:p.Ser313Ter|hmmpanther:PTHR13763&hmmpanther:PTHR13763:SF0&PIRSF_domain:PIRSF001734|||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911|12.0025154251982|11.6681915767273||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|stop_gained&splice_region_variant|HIGH|BRCA1|ENST00000352993|Transcript|13/22||ENST00000352993.3:c.1061C>A|ENSP00000312236.5:p.Ser354Ter|hmmpanther:PTHR13763&hmmpanther:PTHR13763:SF0&PIRSF_domain:PIRSF001734|||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911|12.0025154251982|11.6681915767273||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|intron_variant|MODIFIER|BRCA1|ENST00000354071|Transcript||12/17|ENST00000354071.3:c.4357+7885C>A|||||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911||||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|stop_gained&splice_region_variant|HIGH|BRCA1|ENST00000357654|Transcript|14/23||ENST00000357654.3:c.4487C>A|ENSP00000350283.3:p.Ser1496Ter|hmmpanther:PTHR13763&hmmpanther:PTHR13763:SF0&PIRSF_domain:PIRSF001734|||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911|12.0025154251982|11.6681915767273||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|stop_gained&splice_region_variant|HIGH|BRCA1|ENST00000468300|Transcript|14/22||ENST00000468300.1:c.1175C>A|ENSP00000417148.1:p.Ser392Ter|hmmpanther:PTHR13763&hmmpanther:PTHR13763:SF0&PIRSF_domain:PIRSF001734|||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911|12.0025154251982|11.6681915767273||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|stop_gained&splice_region_variant|HIGH|BRCA1|ENST00000471181|Transcript|15/24||ENST00000471181.2:c.4550C>A|ENSP00000418960.2:p.Ser1517Ter|hmmpanther:PTHR13763:SF0&hmmpanther:PTHR13763&PIRSF_domain:PIRSF001734|||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911|12.0025154251982|11.6681915767273||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|stop_gained&splice_region_variant|HIGH|BRCA1|ENST00000491747|Transcript|14/23||ENST00000491747.2:c.1175C>A|ENSP00000420705.2:p.Ser392Ter|PIRSF_domain:PIRSF001734&hmmpanther:PTHR13763:SF0&hmmpanther:PTHR13763|||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911|12.0025154251982|11.6681915767273||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|stop_gained&splice_region_variant|HIGH|BRCA1|ENST00000493795|Transcript|13/22||ENST00000493795.1:c.4346C>A|ENSP00000418775.1:p.Ser1449Ter|PIRSF_domain:PIRSF001734&hmmpanther:PTHR13763&hmmpanther:PTHR13763:SF0|||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911|12.0025154251982|11.6681915767273||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|upstream_gene_variant|MODIFIER|RPL21P4|ENST00000497954|Transcript||||||||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911||||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|intron_variant|MODIFIER|BRCA1|ENST00000586385|Transcript||1/7|ENST00000586385.1:c.5-10568C>A|||||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911||||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|splice_region_variant&5_prime_UTR_variant|LOW|BRCA1|ENST00000591534|Transcript|2/11||ENST00000591534.1:c.-41C>A|||||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911|12.0025154251982|11.6681915767273||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer",T|intron_variant|MODIFIER|BRCA1|ENST00000591849|Transcript||1/4|ENST00000591849.1:c.-98-24329C>A|||||rs80356953&CM032550||||||||||5.761819||0.57820|0.52911||||||||||55215|pathogenic[p]Familial_cancer_of_breast[c]Breast-ovarian_cancer[c]_familial_1|1.18599998950958|113705_[BRCA1_(confirmed)_Breast-ovarian_cancer&familial&1&604370/Pancreatic_cancer&susceptibility_to&4&614320/Fanconi_anemia&complementation_group_S&617883]|CM1719097|DM|ALT|BRCA1|"Ovarian_cancer";mmsplice=[exon:chr17:41226347-41226538:-,delta_logit_psi:-0.4777,pathogenicity:0.7898]	GT:DP:AO	0/1:102:50
